Okyo Pharma announced plans to sell off some of its shares on Friday, but the ophthalmology-focused biotech clearly had a change of heart over the weekend as the offer was withdrawn this morning over “changing market conditions.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,